The GPhC is reminding all pharmacy professionals of what they must do to ensure women and girls receive the right information about valproate and the risk of birth defects.
The GPhC has issued a statement to give clarity to pharmacy professionals and patients and the public on the supply of the drug Avastin off licence for wet age-related macular degeneration (wet AMD).
Our pharmacyregulation.org website will not be available this evening from 7pm to 9pm due to essential maintenance. We are sorry for any inconvenience this may cause. This will not affect our other websites: mygphc.org or mygphcpharmacy.org.
